IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,566,898 | +1.0% | 107,262 | -3.8% | 0.00% | -33.3% |
Q2 2023 | $5,512,560 | 0.0% | 111,500 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $5,512,560 | -14.4% | 111,500 | -1.2% | 0.00% | 0.0% |
Q4 2022 | $6,443,203 | -99.8% | 112,900 | +43.9% | 0.00% | +50.0% |
Q3 2022 | $3,683,006,000 | – | 78,462 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |